Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β

Koffie, Robert M., Hashimoto, Tadafumi, Tai, Hwan-Ching, Kay, Kevin R., Serrano-Pozo, Alberto, Joyner, Daniel, Hou, Steven, Kopeikina, Katherine J. +5 more·2012·Brain

DOI 10.1093/brain/aws127

Cited by (327)

Items 101–200 of 327

Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
Lewandowski, Cutler T., Maldonado Weng, Juan, LaDu, Mary Jo · 2020 · Neurobiology of Disease
Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease
Shuko Takeda, Tadafumi Hashimoto, Allyson D. Roe, Yukiko Hori, Tara L. Spires‐Jones, Bradley T. Hyman · 2013 · The FASEB Journal
Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer’s disease by fermented soybean nanonutraceutical
Prakash Chandra Bhatt, Shruti Pathak, Vikas Kumar, Bibhu Prasad Panda · 2017 · Inflammopharmacology
Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation
M. Shinohara, R. Petersen, D. Dickson, Guo-Jun Bu · 2013 · Acta Neuropathologica
Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
Bhanu Chandra Karisetty, Akanksha Bhatnagar, Ellen M. Armour, Mariah Beaver, Haolin Zhang, Felice Elefant · 2020 · Frontiers in Molecular Neuroscience
Detecting Early Cognitive Decline in Alzheimer’s Disease with Brain Synaptic Structural and Functional Evaluation
Ribarič, Samo · 2023 · Biomedicines
Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway
Sneha Narasimhan, David M. Holtzman, Liana G. Apostolova, Carlos Cruchaga, Colin Louis Masters, John Hardy, Victor L. Villemagne, J. Simon Bell, Min Cho, Harald Juergen Hampel · 2024 · Nature Neuroscience
Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease
Hatice Kurucu, Martí Colom‐Cadena, Caitlin Davies, Lewis Wilkins, Declan King, Jamie L. Rose, Makis Tzioras, Jane Tulloch, Colin Smith, Tara L. Spires‐Jones · 2021 · European Journal of Neurology
Complement-mediated synapse loss in Alzheimer’s disease: mechanisms and involvement of risk factors
Lang Wen, Danlei Bi, Yong Shen · 2023 · Trends in Neurosciences
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease
Xia, Zengjie, Prescott, Emily E., Urbanek, Agnieszka, Wareing, Hollie E., King, Marianne C., Olerinyova, Anna, Dakin, Helen, Leah, Tom, Barnes, Katy A., Matuszyk, Martyna M. et al. · 2024 · Nature Communications
Monitoring of β-Amyloid Dynamics after Human Traumatic Brain Injury
Niklas Marklund, Nina Farrokhnia, Anders Hånell, Eugeen Vanmechelen, Per Enblad, Henrik Zetterberg, Kaj Blennow, Lars Hillered · 2013 · Journal of Neurotrauma
Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers
Rosemary J. Jackson, Jamie L. Rose, Jane Tulloch, Christopher M. Henstridge, Colin Smith, Tara L. Spires‐Jones · 2019 · Brain Communications
Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients
Manja Lehmann, P. Ghosh, Catherine A. Madison, Anna Karydas, Giovanni Coppola, James P. O’Neil, Yadong Huang, Bruce L. Miller, William Jagust, Gil Dan Rabinovici · 2013 · Journal of Neurology Neurosurgery & Psychiatry
Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice
Pankiewicz, Joanna E, Guridi, Maitea, Kim, Jungsu, Asuni, Ayodeji A, Sanchez, Sandrine, Sullivan, Patrick M, Holtzman, David M, Sadowski, Martin J · 2014 · Acta Neuropathologica Communications
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan · 2024 · Ageing Research Reviews
Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
Liu, Shan, Breitbart, Ariel, Sun, Yanjie, Mehta, Pankaj D., Boutajangout, Allal, Scholtzova, Henrieta, Wisniewski, Thomas · 2014 · Journal of Neurochemistry
Neurotoxic Saboteurs: Straws that Break the Hippo’s (Hippocampus) Back Drive Cognitive Impairment and Alzheimer’s Disease
Mak Adam Daulatzai · 2013 · Neurotoxicity Research
Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology
Sarah E. Monsell, Charles Mock, Catherine M. Roe, Nupur Ghoshal, John C. Morris, Nigel J. Cairns, Walter A. Kukull · 2013 · Neurology
Delirium and A lzheimer disease: A proposed model for shared pathophysiology
Tamara G. Fong, Sarinnapha M. Vasunilashorn, Towia A. Libermann, Edward R. Marcantonio, Sharon K. Inouye · 2019 · International Journal of Geriatric Psychiatry
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
Grant A. Krafft, Jasna Jerecı̀ć, Eric Siemers, Erika N. Cline · 2022 · Frontiers in Neuroscience
Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
Britney N. Lizama, Jennifer S. Kahle, Susan M. Catalano, Anthony O. Caggiano, Michael Grundman, Mary E. Hamby · 2023 · International Journal of Molecular Sciences
VEGF counteracts amyloid-β-induced synaptic dysfunction
Laurent Martin, Pauline Bouvet, Naura Chounlamountri, Chantal Watrin, Roger Besançon, Delphine Pinatel, David Meyronet, Jérôme Honnorat, Alain Buisson, Paul Antoine Salin et al. · 2021 · Cell Reports
The pathophysiology of repetitive concussive traumatic brain injury in experimental models; new developments and open questions
David L. Brody, Joseph Benetatos, Rachel E. Bennett, Kristen C. Klemenhagen, Christine L. Mac Donald · 2015 · Molecular and Cellular Neuroscience
The Study of Postmortem Human Synaptosomes for Understanding Alzheimer’s Disease and Other Neurological Disorders: A Review
Jia-Fong Jhou, Hwan‐Ching Tai · 2017 · Neurology and Therapy
Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
Adam D. Kline · 2012 · Alzheimer s Research & Therapy
The role of genetic risk factors of Alzheimer’s disease in synaptic dysfunction
Fu, Wing-Yu, Ip, Nancy Y. · 2023 · Seminars in Cell & Developmental Biology
Identification of intraneuronal amyloid beta oligomers in locus coeruleus neurons of Alzheimer’s patients and their potential impact on inhibitory neurotransmitter receptors and neuronal excitability
Louise Kelly, Mohsen Seifi, Ruolin Ma, Scott J. Mitchell, Uwe Rudolph, Kirsten L. Viola, William L. Klein, Jeremy J. Lambert, Jerome D. Swinny · 2020 · Neuropathology and Applied Neurobiology
Implicating neuroinflammation in hippocampus, prefrontal cortex and amygdala with cognitive deficit: a narrative review
Vandana Blossom, Sheetal Dinkar Ullal, Melisha M. D’Souza, Anu Vinod Ranade, Nayanatara Arun Kumar, Rajalakshmi Rai · 2025 · 3 Biotech
The Potential Role of Rho GTPases in Alzheimer's Disease Pathogenesis
Silvia Bolognin, Erika Lorenzetto, Giovanni Diana, Mario Buffelli · 2014 · Molecular Neurobiology
Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Manuel Rodriguez‐Perdigon, Rosa María Tordera, Francisco Javier Gil-Bea, Gorka Gereñu, María Javier Ramírez, Maite Solas · 2016 · Hippocampus
Astrocytic and neuronal apolipoprotein E isoforms differentially affect neuronal excitability
Konings, Sabine C., Torres-Garcia, Laura, Martinsson, Isak, Gouras, Gunnar K. · 2021 · Frontiers in Neuroscience
Distinct transcriptomic responses to Aβ plaques, neurofibrillary tangles, and APOE in Alzheimer's disease
Das, Sudeshna, Li, Zhaozhi, Wachter, Astrid, Alla, Srinija, Noori, Ayush, Abdourahman, Aicha, Tamm, Joseph A., Woodbury, Maya E., Talanian, Robert V., Biber, Knut et al. · 2024 · Alzheimer's & Dementia
APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years
Joy L. Taylor, Blake K. Scanlon, Michelle E. Farrell, Beatriz Hernandez, Maheen M. Adamson, John Wesson Ashford, Art M. Noda, Greer M. Murphy, Michael Walter Weiner · 2014 · Neurobiology of Aging
A multi‐hit hypothesis for an APOE4 ‐dependent pathophysiological state
Steele, Oliver George, Stuart, Alexander Cameron, Minkley, Lucy, Shaw, Kira, Bonnar, Orla, Anderle, Silvia, Penn, Andrew Charles, Rusted, Jennifer, Serpell, Louise, Hall, Catherine et al. · 2022 · European Journal of Neuroscience
Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease
Keun-A Chang, Ki Young Shin, Eunjoo Nam, Yeong‐Bae Lee, Cheil Moon, Yoo‐Hun Suh, Sang Hyung Lee · 2016 · Neurochemistry International
The role of N-methyl-D-aspartate glutamate receptors in Alzheimer’s disease: From pathophysiology to therapeutic approaches
Wenying Liu, Yan Li, Tan Zhao, Min Gong, Xuechu Wang, Yue Zhang, Lingzhi Xu, Wenwen Li, Yan Li, Jianping Jia · 2023 · Progress in Neurobiology
RNA Aptamer Probes as Optical Imaging Agents for the Detection of Amyloid Plaques
Christian T. Farrar, Christopher M. William, Eloïse Hudry, Tadafumi Hashimoto, Bradley T. Hyman · 2014 · PLoS ONE
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease
Martí Colom‐Cadena, Jamie Toombs, Elizabeth M. Simzer, Kristján Holt, Robert I. McGeachan, Jane Tulloch, Rosemary J. Jackson, James H. Catterson, Maxwell P Spires-Jones, Jamie L. Rose et al. · 2024 · Acta Neuropathologica
Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse
Christopher M. Henstridge, Rosemary J. Jackson, JeeSoo M. Kim, Abigail G. Herrmann, Ann K. Wright, Sarah E. Harris, Mark E. Bastin, John M. Starr, Joanna Marguerite Wardlaw, Thomas Henry Gillingwater et al. · 2015 · Acta Neuropathologica Communications
Chemical Cross-Linking/Mass Spectrometry Maps the Amyloid β Peptide Binding Region on Both Apolipoprotein E Domains
Stéphanie Deroo, Florian Stengel, Azadeh Mohammadi, Nicolas Henry, Ellen Hubin, Eva‐Maria Krammer, Ruedi H. Aebersold, Vincent Raussens · 2014 · ACS Chemical Biology
Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer’s Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort
Yuek Ling Chai, Hazel Kai Hui Yeo, Jiehao Wang, Saima Hilal, M. Kamran Ikram, Narayanaswamy Venketasubramanian, Boon‐Seng Wong, Christopher Chen · 2016 · Journal of Alzheimer s Disease
Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
Md. Mahiuddin Ahmed, Noah R. Johnson, Timothy D. Boyd, Christina M. Coughlan, Heidi J. Chial, Huntington Potter · 2021 · Frontiers in Aging Neuroscience
Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential
Mi, Yashi, Qi, Guoyuan, Brinton, Roberta Diaz, Yin, Fei · 2021 · Antioxidants & Redox Signaling
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, Zhang Li · 2023 · International Journal of Molecular Sciences
Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer’s disease?
M. Murray, D. Dickson · 2014 · Alzheimer's Research & Therapy
Developmental Perfluorooctanesulfonic acid (PFOS) exposure as a potential risk factor for late-onset Alzheimer’s disease in CD-1 mice and SH-SY5Y cells
Veronia Basaly, Jaunetta Hill, Syed Waseem Bihaqi, Emily Marques, Angela Lucas Slitt, Nasser H. Zawia · 2021 · NeuroToxicology
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Sadequl Islam, A. Noorani, Yang Sun, Makoto Michikawa, Kun Zou · 2025 · Frontiers in Aging Neuroscience
Fluorescent gold nanoclusters for in vivo target imaging of Alzheimer's disease
Lanmei Lai, Chunqiu Zhao, Xiaoqi Li, Xiaoli Liu, Hui Jiang, Matthias Selke, Xuemei Wang · 2016 · RSC Advances
Impact of apolipoprotein E isoforms on sporadic Alzheimer’s disease
Madia Lozupone, Francesco Panza · 2023 · Neural Regeneration Research
Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β
Amanda B. Chai, Hin Hei Julian Lam, Maaike Kockx, Ingrid C. Gelissen · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during aging and in Alzheimer’s disease
Megan E. Jones, Johanna Buechler, Tom Dufor, Ernest Palomer, Samuel Teo, Núria Martín‐Flores, Katharina Boroviak, Emmanouil Metzakopian, Alasdair J. Gibb, Patricia C. Salinas · 2023 · Science Advances
Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease
Robert A. Sweet, Matthew L. MacDonald, Caitlin M. Kirkwood, Ying Ding, Tadhg A. Schempf, Jackie Jones-Laughner, Julia Kofler, Miloš D. Ikonomović, Oscar L. López, Megan E. Garver et al. · 2016 · Molecular & Cellular Proteomics
Combined effects of Aerobic exercise and 40Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3xTg mice.
Sang-Seo Park, Hye-Sang Park, Chang-Ju Kim, Seung-Soo Baek, Song-Young Park, Cody P. Anderson, Myung-Ki Kim, Ik-Ryeul Park, Tae-Woon Kim · 2022 · Journal of applied physiology
Synaptic resilience is associated with maintained cognition during ageing
Declan King, Kristján Holt, Jamie Toombs, Xin He, Owen Dando, Judith A. Okely, Makis Tzioras, Jamie L. Rose, Ciaran Gunn, Adele Correia et al. · 2022 · Alzheimer s & Dementia
Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease
Zhiping Mi, Eric E. Abrahamson, Angela Y. Ryu, Kenneth N. Fish, Robert A. Sweet, Elliott Jay Mufson, Miloš D. Ikonomović · 2017 · Neurobiology of Aging
APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia
Preman, Pranav, Moechars, Daan, Fertan, Emre, Wolfs, Leen, Serneels, Lutgarde, Shah, Disha, Lamote, Jochen, Poovathingal, Suresh, Snellinx, An, Mancuso, Renzo et al. · 2024 · EMBO Molecular Medicine
An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging
Xueying Wang, Ksenia V. Kastanenka, Michal Arbel‐Ornath, Caitlin Commins, Akira Kuzuya, Amanda Lariviere, Grant A. Krafft, Franz F. Hefti, Jasna Jerecı̀ć, Brian J. Bacskai · 2018 · Scientific Reports
Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease
Qiu‐Lan Ma, Edmond Teng, Xiaohong Zuo, Mychica R. Jones, Bruce Teter, Evan Y. Zhao, Cansheng Zhu, Tina V. Bilousova, Karen H. Gylys, Liana G. Apostolova et al. · 2018 · Neurobiology of Disease
The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases
Michael J. Hurley, Robert M. J. Deacon, Katrin Beyer, Elena Ioannou, Agustín M. Ibáñez, Jessica L. Teeling, Patricia Cogram · 2018 · Pharmacology & Therapeutics
CLARITY increases sensitivity and specificity of fluorescence immunostaining in long-term archived human brain tissue
Sarah Woelfle, Dhruva Deshpande, Simone Feldengut, Heiko Braak, Kelly Del Tredici, Francesco Roselli, Karl A. Deisseroth, Jens Michaelis, Tobias M. Boeckers, Michael Schön · 2023 · BMC Biology
APOE ε4 is associated with decreased synaptic density in cognitively impaired participants
He, Kun, Li, Binyin, Wang, Jie, Wang, Ying, You, Zhiwen, Chen, Xing, Chen, Haijuan, Li, Junpeng, Huang, Qi, Guo, Qihao et al. · 2024 · Alzheimer's & Dementia
Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer’s disease in an induced neuron
Hongwon Kim, Junsang Yoo, Jaein Shin, Yu‐Jung Chang, Junghyun Jung, Dong‐Gyu Jo, Janghwan Kim, Wonhee Jang, Christopher J. Lengner, Byung‐Soo Kim et al. · 2017 · Brain
Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer’s disease
Yanhui Zhang, Huiling Gao, Wei Zheng, He Jax Xu · 2022 · Neurobiology of Disease
Neuropathologic features of TOMM40 '523 variant on late‐life cognitive decline
Lei Yu, Michael William Lutz, José M. Farfel, Robert Smith Wilson, Daniel K. Burns, Ann M. Saunders, Philip L. De Jager, Lisa Laverne Barnes, Julie A. Schneider, David Alan Bennett · 2017 · Alzheimer s & Dementia
Body fluid biomarkers in Alzheimer's disease.
Huan Lu, Xi‐Chen Zhu, Teng Jiang, Jin‐Tai Yu, Lan Tan · 2015 · PubMed Central
ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
Ioannis Dafnis, Christina Raftopoulou, Christina Mountaki, Evgenia V. Megalou, Vassilis I. Zannis, Angeliki Chroni · 2018 · Biochemical Journal
Opposing Roles of apolipoprotein E in aging and neurodegeneration
Hudry, Eloise, Klickstein, Jacob, Cannavo, Claudia, Jackson, Rosemary, Muzikansky, Alona, Gandhi, Sheetal, Urick, David, Sargent, Taylie, Wrobleski, Lauren, Roe, Allyson D et al. · 2019 · Life Science Alliance
Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors
Yung‐Chih Kuo, Rajendiran Rajesh · 2019 · Expert Review of Neurotherapeutics
Modified Glutamatergic Postsynapse in Neurodegenerative Disorders
Bruno José Moraes, Patrícia Coelho, Lígia Fão, Ildete L. Ferreira, Ana Cristina Rego · 2019 · Neuroscience
Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer's disease-associated pathogenic effects of apoE4 forms
Christina Mountaki, Ioannis Dafnis, Eirini A. Panagopoulou, Paraskevi B. Vasilakopoulou, Michalis Karvelas, Antonia Chiou, Vaios Τ. Karathanos, Angeliki Chroni · 2021 · Free Radical Biology and Medicine
Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results
Gene L. Bowman, Lisa C. Silbert, Hiroko Hayama Dodge, David L. Lahna, Kirsten Hagen, Charles Murchison, Diane B. Howieson, Jeffrey Alan Kaye, Joseph F. Quinn, Lynne H. Shinto · 2019 · Nutrients
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Madia Lozupone, Bruno Pietro Imbimbo, Claudia Balducci, Filomena Lo Vecchio, Paola Bisceglia, Raffaela Rita Latino, Maurizio Angelo Leone, Vittorio Dibello, Vincenzo Solfrizzi, Antonio Greco et al. · 2022 · Alzheimer s & Dementia
Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, Thi Kim Oanh Nguyen, Vo Van Giau · 2020 · Diagnostics
Selective neuronal vulnerability in Alzheimer's disease.
Zuo-Teng Wang, Can Zhang, Yan-Jiang Wang, Q. Dong, L. Tan, Jin-Tai Yu · 2020 · Ageing Research Reviews
Divergent actions of physiological and pathological amyloid-β on synapses in live human brain slice cultures
R. McGeachan, S. Meftah, Lewis W. Taylor, James H. Catterson, Danilo Negro, Calum Bonthron, K. Holt, J. Tulloch, J. Rose, Francesco Gobbo et al. · 2025 · Nature Communications
Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Cody Allen, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2022 · Alzheimer s Research & Therapy
Lipids and lipoproteins may play a role in the neuropathology of Alzheimer’s disease
Ömer Akyol, Sümeyya Akyol, Mei‐Chuan Chou, Shioulan Chen, Ching‐Kuan Liu, Salih Selek, Jair C. Soares, Chu‐Huang Chen · 2023 · Frontiers in Neuroscience
Structured Illumination Microscopy for the Investigation of Synaptic Structure and Function
Soyon Youngae Hong, Daniel K. Wilton, Beth Stevens, Douglas S. Richardson · 2016 · Methods in molecular biology
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
Pedrini, Steve, Chatterjee, Pratishtha, Hone, Eugene, Martins, Ralph N. · 2021 · Journal of Neurochemistry
Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer’s disease
Karl-Peter Giese · 2014 · Frontiers in Molecular Neuroscience
Close-Range Blast Exposure Is Associated with Altered White Matter Integrity in Apolipoprotein ɛ4 Carriers
Danielle R. Sullivan, Mark W. Logue, Erika J. Wolf, Jasmeet Pannu Hayes, David H. Salat, Catherine B. Fortier, Jennifer R. Fonda, Regina E. McGlinchey, William Milberg, Mark W. Miller · 2019 · Journal of Neurotrauma
Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume
Steve Pedrini, James D. Doecke, Eugene Hone, Penghao Wang, Rohith N. Thota, Ashley Ian Bush, Christopher Cleon Rowe, Vincent Doré, Victor L. Villemagne, David J. Ames et al. · 2022 · Journal of Neurochemistry
A flow cytometry–based in vitro assay reveals that formation of apolipoprotein E (ApoE)–amyloid beta complexes depends on ApoE isoform and cell type
Kara, Eleanna, Marks, Jordan D., Roe, Allyson D., Commins, Caitlin, Fan, Zhanyun, Calvo-Rodriguez, Maria, Wegmann, Susanne, Hudry, Eloise, Hyman, Bradley T. · 2018 · Journal of Biological Chemistry
The Genetics of Alzheimer’s Disease in the Chinese Population
Chen‐Ling Gan, Tao Zhang, Tae Ho Lee · 2020 · International Journal of Molecular Sciences
The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Zhen Xie, Jie Meng, Zhou Wu, Hiroshi Nakanishi, Yoshinori Hayashi, Wei Kong, Fei Lan, Narengaowa, Qinghu Yang, Hong Qing et al. · 2022 · The Neuroscientist
Bringing synapses into focus: Recent advances in synaptic imaging and mass-spectrometry for studying synaptopathy
Nicole Hindley, Anna Sanchez Avila, Christopher M. Henstridge · 2023 · Frontiers in Synaptic Neuroscience
Evidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry
Zhen Huang · 2024 · Journal of Alzheimer s Disease
Alzheimer Disease: The Role of Aβ in the Glutamatergic System
Victoria Campos‐Peña, Marco Antônio · 2014 · InTech eBooks
Synaptic oligomeric tau in Alzheimer’s disease – a potential culprit in the spread of tau pathology through the brain
Martí Colom‐Cadena, Caitlin Davies, Sònia Sirisi, Ji-Eun Lee, Elizabeth M. Simzer, Makis Tzioras, Marta Querol‐Vilaseca, Érika Sánchez‐Aced, Ya Yin Chang, Kristján Holt et al. · 2023 · medRxiv
AD and non‐AD mediators of the pathway between the APOE genotype and cognition
Emma L. Nichols, Adam M. Brickman, Kaitlin Blackstone Casaletto, Kristen Dams-O’Connor, Kristen M. George, Raj G. Kumar, Priya Palta, Jennifer S. Rabin, Claudia Liliana Satizábal, Julie A. Schneider et al. · 2022 · Alzheimer s & Dementia
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Laura Ibáñez, Carlos Cruchaga, María Victoria Fernández · 2021 · Genes
Modelling atherosclerosis by proteomics: Molecular changes in the ascending aortas of cholesterol-fed rabbits
Jingshu Xu, Mia Jüllig, Martin Middleditch, Garth J. S. Cooper · 2015 · Atherosclerosis
Helicobacter pylori outer membrane vesicles directly promote Aβ aggregation and enhance Aβ toxicity in APP/PS1 mice
Dongli Meng, Yi‐Wen Lai, Lun Zhang, Wenting Hu, Hui Wei, Cuiping Guo, Xiaopeng Jing, Huan Zhou, Rui Xiao, Liping Zhu et al. · 2024 · Communications Biology
APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia
Vipin, Ashwati, Kumar, Dilip, Soo, See Ann, Zailan, Fatin Zahra, Leow, Yi Jin, Koh, Chen Ling, Ng, Adeline Su Lyn, Ng, Kok Pin, Kandiah, Nagaendran · 2023 · Alzheimer's Research & Therapy
Apolipoprotein E4 Affects Topographical Changes in Hippocampal and Cortical Atrophy in Alzheimer's Disease Dementia: A Five-Year Longitudinal Study
Yeo Jin Kim, Hanna Cho, Yun Joong Kim, Chang‐Seok Ki, Sun Ju Chung, Byoung Seok Ye, Hee Jin Kim, Jung‐Hyun Kim, Sung Tae Kim, Kyung Han Lee et al. · 2015 · Journal of Alzheimer s Disease
Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40
Natasha Lejbman, Anlys Olivera, Morgan Michelle Heinzelmann, Li Feng, Sijung Yun, Hyungsuk Kim, Jessica Gill · 2016 · Brain Injury
Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology
Sarah E. Monsell, Charles Mock, David W. Fardo, Sarah E. Bertelsen, Nigel J. Cairns, Catherine M. Roe, Sally R. Ellingson, John C. Morris, Alison Goate, Walter A. Kukull · 2016 · Alzheimer Disease & Associated Disorders
Hyperactive glial cells contribute to axonal pathologies in the spinal cord of Npc1 mutant mice
Xin Yan, Fan Yang, Jan Lukáš, Martin Witt, Andreas Wree, Arndt Rolfs, Jiankai Luo · 2014 · Glia
The effect of an APOE polymorphism on cognitive function depends on age
Min‐Ho Shin, Sun‐Seog Kweon, Jin‐Su Choi, Young Hoon Lee, Hae‐Sung Nam, Kyeong-Soo Park, Hee N. Kim, Hye‐Rim Song, Byeong Chae Kim, Seong‐Min Choi et al. · 2013 · Journal of Neurology
Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease
Jie Yeap, Chaitra Sathyaprakash, Jamie Toombs, Jane Tulloch, Cristina Scutariu, Jamie L. Rose, Karen Burr, Caitlin Davies, Martí Colom‐Cadena, Siddharthan Chandran et al. · 2022 · Brain and Neuroscience Advances